Irvine, CA, United States of America

Jahnavi Lokre

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Diality Inc., Axena Health, Inc., Remendium Labs LLC. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jahnavi Lokre. Retrieved from https://idiyas.com/inventor/jahnavi-lokre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Jahnavi Lokre - Revolutionizing Technology

Introduction: Jahnavi Lokre, a brilliant inventor based in Irvine, CA, is making waves in the tech industry with her innovative creations and forward-thinking approach.

Latest Patents: Jahnavi Lokre holds several groundbreaking patents in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing her versatility and ingenuity.

Career Highlights: With a background in engineering and a passion for problem-solving, Jahnavi Lokre has successfully brought to life numerous inventions that have the potential to shape the future of technology.

Collaborations: Known for her collaborative spirit, Jahnavi Lokre has worked with leading research institutions, universities, and tech companies to further develop and implement her cutting-edge ideas.

Conclusion: Jahnavi Lokre's dedication to innovation and her relentless pursuit of excellence continue to establish her as a prominent figure in the world of technology, inspiring the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…